Full text
PDF![315](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/324942/0a4e4262a3ef/thij00055-0077.png)
![316](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/324942/5f2343c1495a/thij00055-0078.png)
![317](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/324942/c0f79cdde25a/thij00055-0079.png)
![318](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/324942/bc2098b9938e/thij00055-0080.png)
![319](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/324942/6ff51bcf0e46/thij00055-0081.png)
![320](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/324942/354701b61f72/thij00055-0082.png)
![321](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/324942/8d589f280f30/thij00055-0083.png)
![322](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/324942/1a0bd0061336/thij00055-0084.png)
![323](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/324942/f290253c67bc/thij00055-0085.png)
![324](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/324942/bc38d2e49fcb/thij00055-0086.png)
![325](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/324942/198f4a82d6fb/thij00055-0087.png)
![326](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/324942/e2c3fe46470f/thij00055-0088.png)
![327](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/324942/069d9bac747c/thij00055-0089.png)
![328](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/324942/b58d93029951/thij00055-0090.png)
![329](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe95/324942/1d8cfe36b02b/thij00055-0091.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BATCHELOR F. R., DOYLE F. P., NAYLER J. H., ROLINSON G. N. Synthesis of penicillin: 6-aminopenicillanic acid in penicillin fermentations. Nature. 1959 Jan 24;183(4656):257–258. doi: 10.1038/183257b0. [DOI] [PubMed] [Google Scholar]
- Bodey G. P., Elting L., Jones P., Alvarez M. E., Rolston K., Fainstein V. Imipenem/cilastatin therapy of infections in cancer patients. Cancer. 1987 Jul 15;60(2):255–262. doi: 10.1002/1097-0142(19870715)60:2<255::aid-cncr2820600224>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
- Bodey G. P., Miller P., Ho D. H. In vitro assessment of sulbactam plus cefoperazone in the treatment of bacteria isolated from cancer patients. Diagn Microbiol Infect Dis. 1989 Jul-Aug;12(4 Suppl):209S–214S. doi: 10.1016/0732-8893(89)90138-7. [DOI] [PubMed] [Google Scholar]
- Childs S. J., Bodey G. P. Aztreonam. Pharmacotherapy. 1986 Jul-Aug;6(4):138–152. doi: 10.1002/j.1875-9114.1986.tb03468.x. [DOI] [PubMed] [Google Scholar]
- Hilf M., Yu V. L., Sharp J., Zuravleff J. J., Korvick J. A., Muder R. R. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med. 1989 Nov;87(5):540–546. doi: 10.1016/s0002-9343(89)80611-4. [DOI] [PubMed] [Google Scholar]
- Kropp H., Gerckens L., Sundelof J. G., Kahan F. M. Antibacterial activity of imipenem: the first thienamycin antibiotic. Rev Infect Dis. 1985 Jul-Aug;7 (Suppl 3):S389–S410. doi: 10.1093/clinids/7.supplement_3.s389. [DOI] [PubMed] [Google Scholar]
- Rodriguez W. J., Schwartz R. H., Khan W. N., Gold A. J. Erythromycin-sulfisoxazole for persistent acute otitis media due to ampicillin-resistant Haemophilus influenzae. Pediatr Infect Dis. 1983 Jan-Feb;2(1):27–29. doi: 10.1097/00006454-198301000-00007. [DOI] [PubMed] [Google Scholar]
- Rolinson G. N. The significance of protein binding of antibiotics in antibacterial chemotherapy. J Antimicrob Chemother. 1980 May;6(3):311–317. doi: 10.1093/jac/6.3.311. [DOI] [PubMed] [Google Scholar]